Melanie M Hagleitner

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. ncbi Age as prognostic factor in patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, 6500HB Nijmegen, The Netherlands
    Bone 49:1173-7. 2011
  2. ncbi Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Pediatr Blood Cancer 56:35-8. 2011

Detail Information

Publications2

  1. ncbi Age as prognostic factor in patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, 6500HB Nijmegen, The Netherlands
    Bone 49:1173-7. 2011
    ..No significant difference was seen between outcomes of patients aged 15-19 years treated at the pediatric or adult oncology department. In conclusion, younger patients have a significantly better outcome than older patients...
  2. ncbi Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcoma
    Melanie M Hagleitner
    Department of Pediatric Hematology and Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
    Pediatr Blood Cancer 56:35-8. 2011
    ..However, this material generally has been decalcified and formalin-fixed for many years. In our study, we investigated whether DNA obtained from these tissues can be used for reliable single nucleotide polymorphism (SNP) genotyping...